Form 4 Tracker
VERTEX PHARMACEUTICALS INC / MA
VRTX

86 insider filings · Latest: Jun 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 1, 2026Apr 3 8:53 PMJoy LiuEVP and Chief Legal Officer
Sale
978$449.17$439.3K21,833(D)

View →

Apr 1, 2026Apr 1 5:02 PMLiu Joy
Proposed Sale
978$449.17$439.3K

View →

Mar 27, 2026Mar 31 8:10 PMCarmen BozicEVP and CMO
Sale
2,329$450.95$1.1M33,076(D)

View →

Mar 27, 2026Mar 27 2:32 PMBozic Carmen
Proposed Sale
2,329$450.95$1.1M

View →

Mar 13, 2026Mar 17 8:04 PMCarmen BozicEVP and CMO
Sale
2,329$481.79$1.1M35,405(D)

View →

Mar 11, 2026Mar 13 8:11 PMDuncan MckechnieEVP, Chief Commercial Officer
Sale
2,633$498.42$1.3M12,489(D)

View →

Mar 13, 2026Mar 13 3:38 PMBozic Carmen
Proposed Sale
2,329$481.79$1.1M

View →

Mar 11, 2026Mar 11 1:44 PMMcKechnie Duncan
Proposed Sale
2,633$498.42$1.3M

View →

Mar 4, 2026Mar 6 9:05 PMDuncan MckechnieEVP, Chief Commercial Officer
Sale
2,437$475.30$1.2M15,122(D)

View →

Mar 2, 2026Mar 4 9:21 PMJoy LiuEVP and Chief Legal Officer
Sale
892$495.96$442.4K22,811(D)

View →

Mar 4, 2026Mar 4 3:09 PMMcKechnie Duncan
Proposed Sale
2,437$475.30$1.2M

View →

Feb 27, 2026Mar 3 9:34 PMReshma KewalramaniDirector, CEO & President
Sale
40,000$493.47$19.7M98,278(D)

View →

Feb 27, 2026Mar 3 9:25 PMCarmen BozicEVP and CMO
Sale
2,329$480.31$1.1M37,734(D)

View →

Mar 2, 2026Mar 2 10:09 PMLiu Joy
Proposed Sale
892$495.96$442.4K

View →

Feb 26, 2026Mar 2 9:10 PMKristen AmbroseSVP & Chief Accounting Officer
Sale
357$483.36$172.6K6,624(D)

View →

Feb 27, 2026Feb 27 9:41 PMKewalramani Reshma
Proposed Sale
40,000$493.47$19.7M

View →

Feb 27, 2026Feb 27 2:50 PMBozic Carmen
Proposed Sale
2,329$480.31$1.1M

View →

Feb 25, 2026Feb 26 11:55 PMOurania TatsisEVP, Chief Reg. & Quality Off.
Sale
260$486.35$126.5K46,763(D)

View →

Feb 25, 2026Feb 26 11:50 PMAmit SachdevEVP Chief Patient & Ext Af Off
Sale
1,846$486.35$897.8K55,570(D)

View →

Feb 25, 2026Feb 26 11:48 PMDuncan MckechnieEVP, Chief Commercial Officer
Sale
4,910$487.65$2.4M17,559(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 1, 2026May 5 9:44 PMSuketu UpadhyayDirector
Grant/Award
3,662$424.453,595.156(D)

View →

May 1, 2026May 5 9:37 PMNancy ThornberryDirector
Grant/Award
1,831$424.45398(D)

View →

May 1, 2026May 5 9:29 PMJennifer SchneiderDirector
Grant/Award
2,229$424.45796(D)

View →

May 1, 2026May 5 9:24 PMBruce I SachsDirector
Grant/Award
2,866$424.452,866(D)

View →

May 1, 2026May 5 9:18 PMDiana MckenzieDirector
Grant/Award
7967,787.483(D)

View →

May 1, 2026May 5 9:06 PMMichel LagardeDirector
Grant/Award
2,866$424.452,866(D)

View →

May 1, 2026May 5 8:58 PMAlan M GarberDirector
Grant/Award
1,433$424.451,433(D)

View →

May 1, 2026May 5 8:54 PMLloyd CarneyDirector
Grant/Award
2,866$424.452,866(D)

View →

Apr 15, 2026Apr 17 8:20 PMSuketu UpadhyayDirector
Grant/Award
80.5082,799.156(D)

View →

Apr 15, 2026Apr 17 8:17 PMBruce I SachsDirector
Grant/Award
107.34515,671.866(D)

View →

Apr 15, 2026Apr 17 8:14 PMAlan M GarberDirector
Grant/Award
33.89833.898(D)

View →

Feb 19, 2026Feb 23 9:21 PMAmit SachdevEVP Chief Patient & Ext Af Off
Option Exercise
48,505$187.530(D)

View →

Jan 15, 2026Jan 20 9:48 PMSuketu UpadhyayDirector
Grant/Award
80.3162,718.648(D)

View →

Jan 15, 2026Jan 20 9:45 PMBruce I SachsDirector
Grant/Award
107.08815,564.521(D)

View →